Abstract Background To investigate influencing factors of the metastatic lymph nodes ratio (MLR) and whether it is related to survival in patients with gastric adenocarcinoma. Methods We retrospectively evaluated the clinical features of 121 patients with gastric adenocarcinoma enrolled in our hospital between 2000 and 2007. The receiver operating characteristic (ROC) curve was used to determine the cutoff of the MLR, and CK20 immunohistochemical staining was used to detect micrometastasis of the lymph nodes. Results The areas under the ROC curve of MLR used to predict the death of 3-year and 5-year postoperative patients were 0.826 ± 0.053 and 0.896 ± 0.046. Thus MLR = 30.95% and MLR = 3.15% were designated as cutoffs. The MLR was then cla...
BACKGROUND:We aimed to investigate effect of increased number of examined lymph nodes (LNs) to pN ca...
OBJECTIVE: The aim of this study was to investigate the prognostic value of metastatic lymph node ra...
Objective:To compare the prognostic performance of American Joint Committee on Cancer/International ...
Abstract Background To demonstrate the prognostic significance and value of lymph node ratio (LNR) a...
Background/Aims: To evaluate whether the ratio between the number of metastatic lymph nodes and the ...
Abstract Background Tumor-node-metastasis (TNM) staging is the central gastric cancer (GC) staging s...
Research on the prognostic value of lymph node ratio (LNR) in gastric cancer (GC) remains limited an...
WOS: 000464383800005PubMed ID: 30870846Background: Lymph node involvement is an important prognostic...
Gastric cancer is one of most common malignancies in the world. Currently the prognostic prediction ...
During the last few years, the gastric cancer nodal staging has been extensively revised. Lately, a ...
edition, metastatic LN ratio (MLR), and log odds of positive LNs (LODDS).Four cohorts with a total ...
Objective: Lymph node metastasis is known to be an important prognostic factor in the gastric cancer...
BACKGROUND: The aim of this study was to investigate the prognostic value of metastatic lymph node (...
Objective: The aim of this study was to investigate the prognostic value of metastatic lymph node ra...
IF 3,824 Abstract: Background: In view of the lack of consensus on the level and number of lymph no...
BACKGROUND:We aimed to investigate effect of increased number of examined lymph nodes (LNs) to pN ca...
OBJECTIVE: The aim of this study was to investigate the prognostic value of metastatic lymph node ra...
Objective:To compare the prognostic performance of American Joint Committee on Cancer/International ...
Abstract Background To demonstrate the prognostic significance and value of lymph node ratio (LNR) a...
Background/Aims: To evaluate whether the ratio between the number of metastatic lymph nodes and the ...
Abstract Background Tumor-node-metastasis (TNM) staging is the central gastric cancer (GC) staging s...
Research on the prognostic value of lymph node ratio (LNR) in gastric cancer (GC) remains limited an...
WOS: 000464383800005PubMed ID: 30870846Background: Lymph node involvement is an important prognostic...
Gastric cancer is one of most common malignancies in the world. Currently the prognostic prediction ...
During the last few years, the gastric cancer nodal staging has been extensively revised. Lately, a ...
edition, metastatic LN ratio (MLR), and log odds of positive LNs (LODDS).Four cohorts with a total ...
Objective: Lymph node metastasis is known to be an important prognostic factor in the gastric cancer...
BACKGROUND: The aim of this study was to investigate the prognostic value of metastatic lymph node (...
Objective: The aim of this study was to investigate the prognostic value of metastatic lymph node ra...
IF 3,824 Abstract: Background: In view of the lack of consensus on the level and number of lymph no...
BACKGROUND:We aimed to investigate effect of increased number of examined lymph nodes (LNs) to pN ca...
OBJECTIVE: The aim of this study was to investigate the prognostic value of metastatic lymph node ra...
Objective:To compare the prognostic performance of American Joint Committee on Cancer/International ...